Dexmedetomidine versus Remifentanil for Sedation during Awake Fiberoptic Intubation

Table 4

Adverse effects observed in patients between the two groups. Data includes intubation attempts, desaturation (SpO₂<90%), hypotension, hypertension, bradycardia, and tachycardia.

	Remifentanil (REM)	Dexmedetomidine (DEX)
Intubation Attempts (1 : 2 : 3); 𝑛 (%)	13 (76%), 3 (18%), 1 (6%)	5 (38%), 4 (31%), 4 (31%)
Desaturation ( SpO2<90%)	6 (35%)	2 (15%)
Hypotension (SBP<90mmHg)	2 (12%)	2 (15%)
Hypertension (SBP<180mmHg)	1 (6%)	2 (15%)
Bradycardia (HR<40bpm)	2 (12%)	1 (8%)
Tachycardia (HR>100bpm)	6 (35%)	7 (53%)

There are no statistical significant differences between the 2 groups.